Off-season RSV epidemics in Australia after easing of COVID-19 restrictions

John‐Sebastian Eden(The University of Sydney), Chisha Sikazwe(The University of Western Australia), Ruopeng Xie(HKU-Pasteur Research Pole), Yi‐Mo Deng(The Royal Melbourne Hospital), Sheena G. Sullivan(The Royal Melbourne Hospital), Alice Michie(The University of Western Australia), Avram Levy(Pathwest Laboratory Medicine), Elena J Cutmore(The University of Sydney), Christopher C. Blyth(The Kids Research Institute Australia), Philip N Britton(The University of Sydney), Nigel W. Crawford(Royal Children's Hospital), Xiaomin Dong(The Royal Melbourne Hospital), Dominic E. Dwyer(The University of Sydney), Kimberly M. Edwards(HKU-Pasteur Research Pole), Bethany A. Horsburgh(The University of Sydney), David A. Foley(Pathwest Laboratory Medicine), Karina Kennedy(Canberra Hospital), Cara Minney‐Smith(Pathwest Laboratory Medicine), David Speers(The University of Western Australia), Rachel L. Tulloch(The University of Sydney), Edward C. Holmes(The University of Sydney), Dhanasekaran Vijaykrishna(HKU-Pasteur Research Pole), David W. Smith(The University of Western Australia), Jen Kok(New South Wales Department of Health), Ian Barr(The Royal Melbourne Hospital), the Australian RSV study group(Murdoch Children's Research Institute), Annette Alafaci(Westmead Hospital), Ian Carter(Royal Children's Hospital), Andrew J. Daley(Royal Children's Hospital), Michelle Francis(The University of Sydney), Alison Kesson(The University of Sydney), Hannah C. Moore(The Kids Research Institute Australia), Christine Ngoc Ngo(Westmead Hospital), Tyna Tran(Westmead Hospital)
Nature Communications
May 24, 2022
Cited by 333Open Access
Full Text

Abstract

Human respiratory syncytial virus (RSV) is an important cause of acute respiratory infection with the most severe disease in the young and elderly. Non-pharmaceutical interventions and travel restrictions for controlling COVID-19 have impacted the circulation of most respiratory viruses including RSV globally, particularly in Australia, where during 2020 the normal winter epidemics were notably absent. However, in late 2020, unprecedented widespread RSV outbreaks occurred, beginning in spring, and extending into summer across two widely separated regions of the Australian continent, New South Wales (NSW) and Australian Capital Territory (ACT) in the east, and Western Australia. Through genomic sequencing we reveal a major reduction in RSV genetic diversity following COVID-19 emergence with two genetically distinct RSV-A clades circulating cryptically, likely localised for several months prior to an epidemic surge in cases upon relaxation of COVID-19 control measures. The NSW/ACT clade subsequently spread to the neighbouring state of Victoria and to cause extensive outbreaks and hospitalisations in early 2021. These findings highlight the need for continued surveillance and sequencing of RSV and other respiratory viruses during and after the COVID-19 pandemic, as mitigation measures may disrupt seasonal patterns, causing larger or more severe outbreaks.


Related Papers

No related papers found

Powered by citation graph analysis